RESEARCH-USE BIOSIMILAR ANTIBODY

Finotonlimab

Monoclonal antibody · IgG4

PDCD1IgG4RUO

Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research.

TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-536
CATALOG NUMBERSC-BS-536
MOLECULAR WEIGHTApprox. 145.38 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research.

Finotonlimab is a recombinant research-use antibody directed against PDCD1.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte